Post Marketing Study to Evaluate the Safety and Effectiveness of Brolucizumab in Patients With Diabetic Macular Edema.
Clinical trial NCT05959304 · COMPLETED
Trial details
- NCT number
- NCT05959304
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-11
- Primary completion
- 2025-11-17
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.